Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that it intends to offer ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Bellerophon Therapeutics (BLPH) Prices 10M Share Common Offering at $0.70/ShJanuary 23, 2019 6:05 AM Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common StockJanuary 22, 2019 4:44 PM